doi:10.1111/j.Assigning a Physical Status classification level is a clinical decision based on multiple factors. Introduction: Mild cognitive impairment: Beyond controversies, towards a consensus. Winblad, B., Palmer, K., Kivipelto, M., et al. Cholinesterase inhibitors for mild cognitive impairment. American Journal of Geriatric Psychiatry, 19, 201–204. A commentary on the proposed DSM revision regarding the classification of cognitive disorders. The global prevalence of dementia: A systematic review and meta-analysis. Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. Mild cognitive impairment: Clinical characterization and outcome. Petersen, R., Smith, G., Waring, S., Ivnik, R., Tangalos, E., & Kokmen, E. International Psychogeriatrics, 21, 225–240. Psychosocial treatments of behavior symptoms in dementia: A systematic review of reports meeting quality standards. O’Connor, D., Ames, D., Gardner, B., & King, M. Journal of the American Geriatrics Society, 53(4), 695–699. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Nasreddine, Z., Phillips, N., & Bédirian, V. National Vital Statistics Reports, 61(4). Acta Psychiatrica Scandinavica, 119, 252–265. Rate of progression of mild cognitive impairment to dementia –meta-analysis of 41 robust inception cohort studies. The Australian and New Zealand Journal of Psychiatry, 47, 779–780. Redefining the syndrome of cognitive impairment in DSM-5. McShane, R., Areosa Sastre, A., & Minakaran, N. Acta Psychiatrica Scandinavica, 131, 29–39. Mild cognitive impairment diagnosed with the new DSM-5 criteria: Prevalence and associations with noncognitive psychopathology. Lopez-Anton, R., Santabárbara, J., De-la-Cámara, C., Gracia-García, P., Lobo, E., Marcos, G., Pirez, G., Saz, P., Haro, J., Rodríguez-Mañas, L., Modrego, P., Dewey, M., & Lobo, A. The Australian and New Zealand Journal of Psychiatry, 48, 284–286. Major and minor neurocognitive disorders in DSM-5: The difference between the map and the terrain. Monetary costs of dementia in the United States. Hurd, M., Martorell, P., Delavande, A., Mullen, K., & Langa, K. Dementia and cognitive impairment: Epidemiology, diagnosis, and treatment. Worldwide prevalence and incidence of dementia. Journal of Psychiatric Research, 12(3), 189–198.įratiglioni, L., De Ronchi, D., & Agüero-Torres, H. A practical method for grading the cognitive state of patients for the clinician. Drug Development Research, 77, 444–452.įolstein, M., Folstein, S., & McHugh, P. Benefits of cognitive treatments administered to patients affected by mild cognitive impairment/mild neurocognitive disorder. The American Journal of Psychiatry, 169(9), 946–953.Ĭavallo, M., Signorino, A., & Perucchini, M. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Cholinesterase inhibitors for Alzheimer’s disease. Archives of Clinical Neuropsychology, 24(1), 31–46.īirks, J. To err is human: “abnormal” neuropsychological scores and variability are common in healthy adults. Dietary patterns and risk of dementia: The three-city cohort study. Arlington: American Psychiatric Association Publishing.īarberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J., & Alpérovitch, A. Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association Publishing.Īmerican Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Mayo Clinic Proceedings, 86(9), 876–884.Īmerican Psychiatric Association. Physical exercise as a preventive or disease modifying treatment of dementia and brain aging. Journal of Clinical Epidemiology, 52, 737–743.Īhlskog, J., Geda, Y., Graff-Radford, N., & Petersen, R. Mortality from dementia in advanced age: A 5-year follow-up study of incident dementia cases. Agüero-Torres, H., Fratiglioni, L., Guo, Z., Viitanen, M., & Winblad, B.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |